BCM
UTMD icon

Bares Capital Management’s Utah Medical Products UTMD Stock Holding History

Bares Capital Management’s Portfolio UTMD Stock Details UTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-303,667
Closed -$15.6M – 59
2014
Q2 		$15.6M Sell
303,667
-88,249
-23% -$4.53M 1.28% 17
2014
Q1 		$22.7M Sell
391,916
-7,021
-2% -$383K 1.81% 16
2013
Q4 		$22.8M Sell
398,937
-22,905
-5% -$1.26M 1.97% 16
2013
Q3 		$25.1M Sell
421,842
-573
-0.1% -$31.3K 2.34% 17
2013
Q2 		$22.9M Buy
+422,415
New +$19.9M 2.24% 16

Other funds holding UTMD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
MDCM
Morgan Dempsey Capital Management Menomonee Falls, Wisconsin $220M AUM 18.32% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bares Capital Management's UTMD Position: Q3 2014 in Review

Bares Capital Management sold out of Utah Medical Products (UTMD) in Q3 2014, closing a stake of 303,667 shares — an estimated $15.6M sold.

Bares Capital Management first reported a position in UTMD in Q2 2013 and held it in 5 quarters. The position peaked at $25.1M in Q3 2013. 62 funds tracked by Wall St. Rank hold UTMD as of Q3 2014.

  • Bares Capital Management reported no remaining Utah Medical Products position as of Q3 2014 after selling out during the quarter.
  • Bares Capital Management sold 303,667 Utah Medical Products shares in Q3 2014, an estimated $15.6M.
  • Bares Capital Management first reported a position in Utah Medical Products in Q2 2013 and held it in 5 quarters.
  • Bares Capital Management's Utah Medical Products position peaked at $25.1M in Q3 2013.
  • 62 funds tracked by Wall St. Rank held Utah Medical Products as of Q3 2014.

Based on Bares Capital Management's 13F filing for Q3 2014, filed 14 Nov 2014.